Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 19/8/2019
SIETES contiene 92796 citas

 
 
 1 a 20 de 27 siguiente >>
Presentar resultados
Seleccionar todas
1. Cita con resumen
Coupland CAC, Hill T, Dening T, Morriss R, Moore M, Hippisley-Cox J. Anticholinergic drug exposure and the risk of dementia. A nested case-control study. JAMA Intern Med 2019:24 de junio. [Ref.ID 103160]
2. Cita con resumen
Maier L, Pruteanu M, Kuhn M, Zeller G, Telzerow A, Anderson EE, Brochado AR, Fernandez KC, Dose H, Mori H, Patil KR, Bork P, Typas A. Extensive impact of non-antibiotic drugs on human gut bacteria. Nature 2018;555:29 de marzo. [Ref.ID 102577]
4.Tiene citas relacionadas Cita con resumen
Liperoti R, Gambassi G. Antipsychotics and the risk of venous thromboembolism. BMJ 2010;341:613-4. [Ref.ID 89403]
5.
Anónimo. Neuroleptiques: troubles de la déglutition. Prescrire 2010;30:746-8. [Ref.ID 89217]
6. Cita con resumen
Anónimo. Patients âgés déments et neuroleptiques: excès de mortalité. Prescrire 2010;30:427-9. [Ref.ID 88568]
7.Enlace a cita original Cita con resumen
Ballard C, Hanney ML, Theodoulou M, Douglas S, McShane R, Kossakowski K, Gill R, Juszczak E, Yu LM, Jacoby R, for the DART-AD Investigators. The dementia antipsychotic withdrawal trial (DART-AD): long-term follow-up of a randomised placebo-controlled trial. Lancet Neurol 2009;8:151-7. [Ref.ID 84960]
8.Tiene citas relacionadas Cita con resumen
Newham JJ, Thomas SH, MacRitchie K, McElhatton PR, McAllister-Williams RH. Birth weight of infants after maternal exposure to typical and atypical antipsychotics: prospective comparison study. Br J Psychiatry 2008;195:333-7. [Ref.ID 83563]
9. Cita con resumen
Anónimo. Neuroleptics could cause early death in Alzheimer's patients. Scrip 2007;3249/50:31. [Ref.ID 79797]
10. Cita con resumen
Byrne P. Managing the acute psychotic episode. BMJ 2007;334:686-92. [Ref.ID 79707]
11. Cita con resumen
Tyrer P, Baldwin D. Generalised anxiety disorder. Lancet 2006;368:2156-66. [Ref.ID 78679]
12. Cita con resumen
Lieb K, Zanarini MC, Schmahl C, Linehan MM, Bohus M. Borderline personality disorder. Lancet 2004;364:453-61. [Ref.ID 70990]
13.
Anónimo. Choice of antipsychotic. Med Lett Drugs Ther 2003;45:102-4. [Ref.ID 68639]
14.
Madhusoodanan S, Bogunovic OJ, Moise D, Brenner R, Markowitz S, Sotelo J. Hyponatraemia associated with psychotropic medications: a review of the literature and spontaneous reports. Adverse Drug React Toxicol Rev 2002;21:17-29. [Ref.ID 62070]
16.
De Ponti F, Poluzzi E, Cavalli A, Recanatini M, Montanaro N. Safety of non-antiarrhythmic drugs that prolong the QT interval or induce torsade de pointes: an overview. Drug Saf 2002;25:263-86. [Ref.ID 61881]
17.
Yap YG, Camm J. Risk of torsades de pointes with non-cardiac drugs. BMJ 2000;320:1158-9. [Ref.ID 50659]
19. Cita con resumen
Nimmagadda S R, Ryan D H, Atkin SL. Neuroleptic malignant syndrome after venlafaxine. Lancet 2000;355:289-90. [Ref.ID 49028]
20.
Anónimo. Tranylcypromine/trifluoperazine - Licence not renewed. United Kingdom. WHO Pharmaceuticals Newsletter 1999;7-8:6. [Ref.ID 47555]
Seleccionar todas
 
 1 a 20 de 27 siguiente >>